WallStreetZenWallStreetZen

NASDAQ: ATRA
Atara Biotherapeutics Revenue

OverviewForecastEarningsRevenue
DividendOwnership
Atara Biotherapeutics revenue was $151.93M for the trailing 12 months ending Sep 30, 2025, with N/A growth year over year. Quarterly revenue for the quarter (Q3 2025) ending on Sep 30, 2025 was $3.5M, down 80.4% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, ATRA annual revenue was $128.9M, with 1,404% growth year-over-year.

ATRA past revenue growth

How has ATRA's revenue growth performed historically?

Company
51.27%
Industry
304.68%
Market
21.11%
ATRA's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
ATRA's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Market Performance
ATRA's revenue growth is accelerating... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

ATRA revenue history

Current Revenue
$151.9M
Current Earnings
$23.4M
Current Profit Margin
15.4%
ATRA's has not demonstrated consistent... subscribe to Premium to read more.
Long-term Earnings Growth Trend Performance

Be the first to know when ATRA announces revenue.

ATRA Revenue History By Year

ATRA Yearly RevenueATRA RevenueATRA ChangeATRA Revenue Growth
2024-12-31$128.94M$120.37M+1,404.02%
2023-12-31$8.57M-$55.00M-86.51%
2022-12-31$63.57M$43.23M+212.55%
2021-12-31$20.34MN/AN/A
2020-12-31$0.00N/AN/A
2019-12-31$0.00N/AN/A
2018-12-31$0.00N/AN/A
2017-12-31$0.00N/AN/A
2016-12-31$0.00N/AN/A
2015-12-31$0.00N/AN/A
2014-12-31$0.00N/AN/A
2013-12-31$0.00N/AN/A

1 of 1

Atara Biotherapeutics Revenue FAQ

What was ATRA's revenue last quarter?

Atara Biotherapeutics (NASDAQ: ATRA) reported Q3 2025 revenue of $3.45 million up 91.41% year over year. In the same quarter last year, Atara Biotherapeutics's revenue was $40.19 million.

What was Atara Biotherapeutics's revenue in 2024?

Atara Biotherapeutics's annual revenue for the twelve months ending Dec 31, 2024 was $128.94 million, a 1,404.02% increase year over year.

How much does Atara Biotherapeutics make in a day?

Based on Atara Biotherapeutics annual revenue for the past five years, ATRA makes an average of $121,329.32 per day.

What was Atara Biotherapeutics's annual revenue growth in the past year?

As of Q4 2025, Atara Biotherapeutics's revenue has grown 51.27% year over year. This is 253.41 percentage points lower than the US Biotechnology industry revenue growth rate of 304.68%. Atara Biotherapeutics's revenue in the past year totaled $151.93 million.

How much does Atara Biotherapeutics make in a year?

Atara Biotherapeutics's revenue by year for the past five years is:
  • Atara Biotherapeutics's revenue for the twelve months ending Dec 31, 2024 was $128.94 million, a 1,404.02% increase year over year.
  • Atara Biotherapeutics's annual revenue for Dec 31, 2023 was $8.57 million, a 86.51% decrease from 2022.
  • Atara Biotherapeutics's annual revenue for 2022 was $63.57 million, a 212.55% increase from 2021.
  • Atara Biotherapeutics's annual revenue for 2021 was $20.34 million, a Infinity% increase from 2020.
  • Atara Biotherapeutics's annual revenue for 2020 was $0.00, a N/A decrease from 2019.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.